General Medicine and Primary Care

Host: Linda Bernstein, Pharm.D.

The U.S. Food and Drug Administration has granted Eli Lilly and Company’s trial vaccine for COVID-19 an Emergency Use Authorization, or EUA. On this episode of The Drug Report, learn more about this monoclonal antibody and how the company plans on distributing it.

Published November 30, 2020

Host: Linda Bernstein, Pharm.D.

In light of the COVID-19 pandemic, the Centers for Disease Control and Prevention, or the CDC, plans to use pharmacies to increase access to the COVID-19 vaccine when it is ready for distribution. In this episode of The Drug Report, Linda Bernstein will explain the CDC’s recently-developed Vaccination Program Interim Playbook.

Published November 17, 2020

Host: Linda Bernstein, Pharm.D.

The Food and Drug Administration announced that Remdesivir is the first treatment for COVID-19 to receive their approval. To help us better understand this antiviral agent, Dr. Linda Bernstein discusses emerging studies uncovering the benefits and limitations of Remdesivir.

Published November 6, 2020

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Douglas Drossman, MD

Developed to treat psychiatric disorders, emerging evidence suggests that neuromodulators play a vital role in treating functional GI disorders. Here today is Dr. Peter Buch who will be discussing the role of neuromodulators in functional GI disorders with Dr. Douglas Drossman.

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Douglas Drossman, MD

Effective communication is essential to improving the patient-provider relationship. What is the best approach a physician can take when speaking to patients with IBS? Dr. Peter Buch will discuss valuable communication strategies with Dr. Douglas Drossman, president of the Rome Foundation.

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Lawrence Schiller, MD, FAP, FACG

Patients with chronic diarrhea are often misdiagnosed with irritable bowel syndrome with diarrhea, or IBS-D. How can we better assess these patients to prevent misdiagnosis? Joining Dr. Peter Buch to discuss diagnostic tools and testing strategies is Dr. Lawrence Schiller, Program Director of the Gastroenterology Fellowship at Baylor University Medical Center.

Host: Shira Johnson, MD

Guest: Sabrina E. Noel, PhD, RD

While osteoporosis was thought to have affected primarily non-Hispanic white women, recent evidence suggests that Hispanic men and women have a similar or higher frequency of this chronic condition. Dr. Sabrina E. Noel, Ph.D., R.D., discusses her studies regarding the prevalence of osteoporosis in the Hispanic community.

Host: Shira Johnson, MD

Guest: Andrea J. Singer, MD, FACP, CCD

While osteoporosis-related bone fractures affect nearly 54 million adults in the U.S., there’s a lot we don’t know about this bone disease. With that in mind, Dr. Andrea Singer joins us today to review a recent report from the National Osteoporosis Foundation and discuss the impact of osteoporosis on economic drivers, patient quality of life, and the healthcare system as a whole.

Host: Mikhail Kosiborod, MD

Despite evidence and guideline recommendations, renin-angiotensin-aldosterone system inhibitor (RAASi) therapy tends to be used suboptimally among patients with heart failure (HF), particularly in patients with chronic kidney disease (CKD). What are the real-world factors that influence RAASi treatment decisions in patients with HF who have or are at risk for hyperkalemia? Hear about how the CARE HK in HF study is being designed to explore the real-world data surrounding this question and its associated impact on outcomes.

Host: Timothy Aksamit, MD

Guest: Amy Levinger, MSN, FNP-C

Guest: David E. Griffith, MD

The prevalence of non-tuberculous mycobacterial (NTM) lung disease in the United States has almost doubled between 2008 and 2015. But despite this increase, its diagnosis can often be delayed, which is why pulmonary nurse practitioner Amy Levinger and Dr. David Griffith join Dr. Tim Aksamit to discuss the diagnostic criteria, tools that can help us make a timely diagnosis of NTM lung disease, and more.

For more information and to access clinician & patient tools about NTM and MAC Lung Disease, click here to visit the CHEST Foundation NTM webpage.

This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.